$COLY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Coley Pharmaceutical Group, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Coley Pharmaceutical Group, Inc.. Get notifications about new insider transactions in Coley Pharmaceutical Group, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 31 2008 | COLY | Coley Pharmaceutic ... | BATE KENNETH | Director | Option Exercise | U | 1.15 | 21,834 | 25,109 | 0 | |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R & D, Chief S ... | Option Exercise | U | 3.13 | 55,000 | 172,150 | 0 | |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R & D, Chief S ... | Option Exercise | U | 1.15 | 94,788 | 109,006 | 0 | |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R & D, Chief S ... | Option Exercise | U | 1.15 | 13,646 | 15,693 | 0 | |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R & D, Chief S ... | Option Exercise | U | 1.15 | 153,672 | 176,723 | 0 | |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R & D, Chief S ... | Sell | U | 0.00 | 5,240 | 0 | 0 | 5.2 K to 0 (-100.00 %) |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R & D, Chief S ... | Sell | U | 0.00 | 5,240 | 0 | 0 | 5.2 K to 0 (-100.00 %) |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R & D, Chief S ... | Sell | U | 0.00 | 5,240 | 0 | 0 | 5.2 K to 0 (-100.00 %) |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R & D, Chief S ... | Sell | U | 0.00 | 545,602 | 0 | 0 | 545.6 K to 0 (-100.00 %) |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Abdalian Charles H Jr | SVP, Finance and CF ... | Option Exercise | U | 1.15 | 8,666 | 9,966 | 0 | |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Abdalian Charles H Jr | SVP, Finance and CF ... | Option Exercise | U | 3.13 | 40,000 | 125,200 | 0 | |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Abdalian Charles H Jr | SVP, Finance and CF ... | Option Exercise | U | 1.15 | 58,123 | 66,841 | 0 | |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Abdalian Charles H Jr | SVP, Finance and CF ... | Option Exercise | U | 1.15 | 52,402 | 60,262 | 0 | |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Massari Ferdinand E | Sr. VP of Drug Deve ... | Option Exercise | U | 3.13 | 65,000 | 203,450 | 0 | |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Bratzler Robert L | President and CEO | Option Exercise | U | 3.13 | 70,000 | 219,100 | 0 | |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Bratzler Robert L | President and CEO | Option Exercise | U | 1.15 | 168,258 | 193,497 | 0 | |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Bratzler Robert L | President and CEO | Option Exercise | U | 1.15 | 356,987 | 410,535 | 0 | |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Bratzler Robert L | President and CEO | Sell | U | 0.00 | 150,654 | 0 | 0 | 150.7 K to 0 (-100.00 %) |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Bratzler Robert L | President and CEO | Sell | U | 0.00 | 308,697 | 0 | 0 | 308.7 K to 0 (-100.00 %) |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | HUGIN ROBERT J | Director | Option Exercise | U | 1.15 | 21,834 | 25,109 | 0 | |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Langlois Patrick | Director | Option Exercise | U | 1.15 | 21,834 | 25,109 | 0 | |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Karobath Manfred E | Director | Option Exercise | U | 5.64 | 11,358 | 64,059 | 0 | |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Karobath Manfred E | Director | Option Exercise | U | 1.15 | 4,549 | 5,231 | 0 | |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Karobath Manfred E | Director | Option Exercise | U | 1.15 | 3,753 | 4,316 | 0 | |
Jan 25 2008 | COLY | Coley Pharmaceutic ... | Karobath Manfred E | Director | Sell | U | 0.00 | 135,783 | 0 | 0 | 135.8 K to 0 (-100.00 %) |
Dec 14 2007 | COLY | Coley Pharmaceutic ... | Karobath Manfred E | Director | Sell | S | 7.93 | 27,000 | 214,110 | 135,783 | 162.8 K to 135.8 K (-16.59 %) |
Sep 20 2007 | COLY | Coley Pharmaceutic ... | Abdalian Charles H Jr | SVP, Finance and CF ... | Option Exercise | A | 3.13 | 40,000 | 125,200 | 40,000 | |
Sep 20 2007 | COLY | Coley Pharmaceutic ... | Bratzler Robert L | President and CEO | Option Exercise | A | 3.13 | 70,000 | 219,100 | 70,000 | |
Sep 20 2007 | COLY | Coley Pharmaceutic ... | Massari Ferdinand E | Sr. VP of Drug Deve ... | Option Exercise | A | 3.13 | 65,000 | 203,450 | 65,000 | |
Sep 20 2007 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R & D, Chief S ... | Option Exercise | A | 3.13 | 55,000 | 172,150 | 55,000 | |
Aug 29 2007 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R & D, Chief S ... | Sell | S | 1.89 | 21,070 | 39,822 | 545,602 | 566.7 K to 545.6 K (-3.72 %) |
Jun 15 2007 | COLY | Coley Pharmaceutic ... | BATE KENNETH | Director | Option Exercise | A | 8.02 | 5,459 | 43,781 | 5,459 | |
Jun 15 2007 | COLY | Coley Pharmaceutic ... | HUGIN ROBERT J | Director | Option Exercise | A | 8.02 | 5,459 | 43,781 | 5,459 | |
Jun 15 2007 | COLY | Coley Pharmaceutic ... | Langlois Patrick | Director | Option Exercise | A | 8.02 | 5,459 | 43,781 | 5,459 | |
Jun 15 2007 | COLY | Coley Pharmaceutic ... | Karobath Manfred E | Director | Option Exercise | A | 8.02 | 5,459 | 43,781 | 5,459 | |
May 14 2007 | COLY | Coley Pharmaceutic ... | THOMAS JAMES E | Director | Buy | P | 8.66 | 60,000 | 519,600 | 2,035,940 | 2 M to 2 M (+3.04 %) |
May 14 2007 | COLY | Coley Pharmaceutic ... | THOMAS JAMES E | Director | Buy | P | 8.68 | 100,000 | 868,000 | 1,975,940 | 1.9 M to 2 M (+5.33 %) |
May 09 2007 | COLY | Coley Pharmaceutic ... | Karobath Manfred E | Director | Buy | P | 8.98 | 7,000 | 62,860 | 162,783 | 155.8 K to 162.8 K (+4.49 %) |
May 09 2007 | COLY | Coley Pharmaceutic ... | Karobath Manfred E | Director | Buy | P | 9.01 | 5,000 | 45,050 | 155,783 | 150.8 K to 155.8 K (+3.32 %) |
May 09 2007 | COLY | Coley Pharmaceutic ... | Karobath Manfred E | Director | Buy | P | 9.00 | 5,000 | 45,000 | 150,783 | 145.8 K to 150.8 K (+3.43 %) |
May 09 2007 | COLY | Coley Pharmaceutic ... | Karobath Manfred E | Director | Buy | P | 8.99 | 5,000 | 44,950 | 145,783 | 140.8 K to 145.8 K (+3.55 %) |
May 09 2007 | COLY | Coley Pharmaceutic ... | Karobath Manfred E | Director | Buy | P | 9.22 | 5,000 | 46,100 | 140,783 | 135.8 K to 140.8 K (+3.68 %) |
Feb 21 2007 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R&D, Chief Sci ... | Option Exercise | A | 9.86 | 50,000 | 493,000 | 50,000 | |
Feb 21 2007 | COLY | Coley Pharmaceutic ... | Massari Ferdinand E | SVP, Drug Dev. & CM ... | Option Exercise | A | 9.86 | 60,000 | 591,600 | 60,000 | |
Feb 21 2007 | COLY | Coley Pharmaceutic ... | Bratzler Robert L | President & CEO | Option Exercise | A | 9.86 | 90,000 | 887,400 | 90,000 | |
Feb 21 2007 | COLY | Coley Pharmaceutic ... | Abdalian Charles H Jr | SVP Finance & CFO | Option Exercise | A | 9.86 | 45,000 | 443,700 | 45,000 | |
Dec 11 2006 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R & D, Chief S ... | Gift | G | 0.00 | 300 | 0 | 566,672 | 567 K to 566.7 K (-0.05 %) |
Dec 11 2006 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R & D, Chief S ... | Sell | S | 2.24 | 18,122 | 40,593 | 566,972 | 585.1 K to 567 K (-3.10 %) |
Oct 16 2006 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R & D, Chief S ... | Sell | S | 1.89 | 13,210 | 24,967 | 585,094 | 598.3 K to 585.1 K (-2.21 %) |
Jun 27 2006 | COLY | Coley Pharmaceutic ... | Massari Ferdinand E | Sr. VP of Drug Deve ... | Option Exercise | A | 11.37 | 80,000 | 909,600 | 80,000 | |
Jun 22 2006 | COLY | Coley Pharmaceutic ... | BATE KENNETH | Director | Option Exercise | A | 11.80 | 5,459 | 64,416 | 5,459 | |
Jun 22 2006 | COLY | Coley Pharmaceutic ... | Karobath Manfred E | Director | Option Exercise | A | 11.80 | 5,459 | 64,416 | 5,459 | |
Jun 22 2006 | COLY | Coley Pharmaceutic ... | Langlois Patrick | Director | Option Exercise | A | 11.80 | 5,459 | 64,416 | 5,459 | |
Jun 22 2006 | COLY | Coley Pharmaceutic ... | HUGIN ROBERT J | Director | Option Exercise | A | 11.80 | 5,459 | 64,416 | 5,459 | |
May 31 2006 | COLY | Coley Pharmaceutic ... | THOMAS MCNERNEY & PARTNERS LP | 10% Owner | Sell | J | 0.00 | 3,680 | 0 | 2,408,138 | 2.4 M to 2.4 M (-0.15 %) |
May 31 2006 | COLY | Coley Pharmaceutic ... | THOMAS MCNERNEY & PARTNERS LP | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 2,411,818 | 3.4 M to 2.4 M (-29.31 %) |
May 31 2006 | COLY | Coley Pharmaceutic ... | THOMAS JAMES E | Director | Buy | J | 0.00 | 2,692 | 0 | 2,410,830 | 2.4 M to 2.4 M (+0.11 %) |
May 31 2006 | COLY | Coley Pharmaceutic ... | THOMAS JAMES E | Director | Sell | J | 0.00 | 3,680 | 0 | 2,408,138 | 2.4 M to 2.4 M (-0.15 %) |
May 31 2006 | COLY | Coley Pharmaceutic ... | THOMAS JAMES E | Director | Sell | J | 0.00 | 1,000,000 | 0 | 2,411,818 | 3.4 M to 2.4 M (-29.31 %) |
May 10 2006 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R & D, Chief S ... | Sell | D | 14.34 | 24,579 | 352,463 | 598,304 | 622.9 K to 598.3 K (-3.95 %) |
Apr 20 2006 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R & D, Chief S ... | Option Exercise | M | 1.15 | 21,000 | 24,150 | 153,672 | |
Apr 20 2006 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R & D, Chief S ... | Buy | M | 1.15 | 21,000 | 24,150 | 622,883 | 601.9 K to 622.9 K (+3.49 %) |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Option Exercise | X | 5.64 | 239,490 | 1,350,005 | 0 | |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Option Exercise | C | 0.00 | 3,404,278 | 0 | 0 | |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Option Exercise | C | 0.00 | 3,874,649 | 0 | 0 | |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Buy | X | 0.00 | 239,490 | 0 | 1,960,735 | 1.7 M to 2 M (+13.91 %) |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Buy | C | 0.00 | 743,292 | 0 | 1,721,245 | 978 K to 1.7 M (+76.00 %) |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Buy | C | 0.00 | 977,953 | 0 | 977,953 | 0 to 978 K |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM MEDICAL VENTURES GMBH & CO ... | 10% Owner | Option Exercise | C | 0.00 | 188,064 | 0 | 0 | |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM MEDICAL VENTURES GMBH & CO ... | 10% Owner | Option Exercise | C | 0.00 | 673,500 | 0 | 0 | |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM MEDICAL VENTURES GMBH & CO ... | 10% Owner | Buy | C | 0.00 | 91,201 | 0 | 342,816 | 251.6 K to 342.8 K (+36.25 %) |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM MEDICAL VENTURES GMBH & CO ... | 10% Owner | Buy | C | 0.00 | 251,615 | 0 | 251,615 | 0 to 251.6 K |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM IV GMBH & CO KG | 10% Owner | Option Exercise | X | 5.64 | 26,610 | 150,001 | 0 | |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM IV GMBH & CO KG | 10% Owner | Option Exercise | C | 0.00 | 430,520 | 0 | 0 | |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM IV GMBH & CO KG | 10% Owner | Option Exercise | C | 0.00 | 470,161 | 0 | 0 | |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM IV GMBH & CO KG | 10% Owner | Buy | X | 0.00 | 26,610 | 0 | 363,275 | 336.7 K to 363.3 K (+7.90 %) |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM IV GMBH & CO KG | 10% Owner | Buy | C | 0.00 | 108,661 | 0 | 336,665 | 228 K to 336.7 K (+47.66 %) |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM IV GMBH & CO KG | 10% Owner | Buy | C | 0.00 | 228,004 | 0 | 228,004 | 0 to 228 K |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM III Limited Partnership | 10% Owner | Option Exercise | C | 0.00 | 539,000 | 0 | 0 | |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM III Limited Partnership | 10% Owner | Option Exercise | X | 9.94 | 36,985 | 367,461 | 0 | |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM III Limited Partnership | 10% Owner | Option Exercise | X | 9.94 | 147,008 | 1,460,598 | 0 | |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM III Limited Partnership | 10% Owner | Option Exercise | C | 0.00 | 473,000 | 0 | 0 | |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM III Limited Partnership | 10% Owner | Buy | C | 0.00 | 201,366 | 0 | 556,235 | 354.9 K to 556.2 K (+56.74 %) |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM III Limited Partnership | 10% Owner | Buy | X | 0.00 | 36,985 | 0 | 354,869 | 317.9 K to 354.9 K (+11.63 %) |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM III Limited Partnership | 10% Owner | Buy | X | 0.00 | 147,008 | 0 | 317,884 | 170.9 K to 317.9 K (+86.03 %) |
Nov 02 2005 | COLY | Coley Pharmaceutic ... | TVM III Limited Partnership | 10% Owner | Buy | C | 0.00 | 170,876 | 0 | 170,876 | 0 to 170.9 K |
Sep 29 2005 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R& D, Chief Sc ... | Option Exercise | A | 16.00 | 73,515 | 1,176,240 | 367,538 | |
Sep 29 2005 | COLY | Coley Pharmaceutic ... | Abdalian Charles H Jr | SVP, Finance and CF ... | Option Exercise | A | 16.00 | 37,117 | 593,872 | 156,308 | |
Sep 29 2005 | COLY | Coley Pharmaceutic ... | Bratzler Robert L | President and CEO | Option Exercise | A | 16.00 | 238,318 | 3,813,088 | 790,856 | |
Aug 17 2005 | COLY | Coley Pharmaceutic ... | Karobath Manfred E | Director | Option Exercise | C | 0.22 | 300,000 | 65,400 | 0 | |
Aug 17 2005 | COLY | Coley Pharmaceutic ... | Karobath Manfred E | Director | Option Exercise | C | 0.25 | 183,756 | 46,307 | 0 | |
Aug 17 2005 | COLY | Coley Pharmaceutic ... | Karobath Manfred E | Director | Option Exercise | C | 0.51 | 17,537 | 8,979 | 0 | |
Aug 17 2005 | COLY | Coley Pharmaceutic ... | Karobath Manfred E | Director | Sell | C | 0.00 | 65,502 | 0 | 135,783 | 201.3 K to 135.8 K (-32.54 %) |
Aug 17 2005 | COLY | Coley Pharmaceutic ... | Karobath Manfred E | Director | Buy | C | 0.00 | 46,379 | 0 | 135,783 | 89.4 K to 135.8 K (+51.88 %) |
Aug 17 2005 | COLY | Coley Pharmaceutic ... | Karobath Manfred E | Director | Buy | C | 0.00 | 8,983 | 0 | 135,783 | 126.8 K to 135.8 K (+7.08 %) |
Aug 17 2005 | COLY | Coley Pharmaceutic ... | Bratzler Robert L | President and CEO | Option Exercise | C | 0.22 | 476,500 | 103,877 | 0 | |
Aug 17 2005 | COLY | Coley Pharmaceutic ... | Bratzler Robert L | President and CEO | Option Exercise | C | 0.22 | 335,993 | 73,246 | 0 | |
Aug 17 2005 | COLY | Coley Pharmaceutic ... | Bratzler Robert L | President and CEO | Buy | C | 0.00 | 104,039 | 0 | 150,654 | 46.6 K to 150.7 K (+223.19 %) |
Aug 17 2005 | COLY | Coley Pharmaceutic ... | Bratzler Robert L | President and CEO | Buy | C | 0.00 | 73,360 | 0 | 308,697 | 235.3 K to 308.7 K (+31.17 %) |
Aug 17 2005 | COLY | Coley Pharmaceutic ... | Caspritz Gert | Director | Option Exercise | C | 0.22 | 3,404,278 | 742,133 | 0 | |
Aug 17 2005 | COLY | Coley Pharmaceutic ... | Caspritz Gert | Director | Option Exercise | C | 0.25 | 4,305,169 | 1,084,903 | 0 | |
Aug 17 2005 | COLY | Coley Pharmaceutic ... | Caspritz Gert | Director | Option Exercise | C | 0.22 | 3,000 | 654 | 0 | |
Aug 17 2005 | COLY | Coley Pharmaceutic ... | Caspritz Gert | Director | Buy | C | 0.00 | 743,292 | 0 | 743,292 | 0 to 743.3 K |
Aug 17 2005 | COLY | Coley Pharmaceutic ... | Caspritz Gert | Director | Buy | C | 0.00 | 1,086,615 | 0 | 1,086,615 | 0 to 1.1 M |
Aug 17 2005 | COLY | Coley Pharmaceutic ... | Caspritz Gert | Director | Buy | C | 0.00 | 655 | 0 | 4,221 | 3.6 K to 4.2 K (+18.37 %) |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Option Exercise | C | 0.00 | 2,870,582 | 0 | 0 | |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Option Exercise | C | 0.00 | 5,510,611 | 0 | 0 | |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Buy | C | 0.00 | 626,764 | 0 | 2,017,630 | 1.4 M to 2 M (+45.06 %) |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VENROCK MANAGEMENT III LLC | 10% Owner | Buy | C | 0.00 | 1,390,866 | 0 | 1,390,866 | 0 to 1.4 M |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VEF MANAGEMENT III LLC | 10% Owner | Option Exercise | C | 0.00 | 71,764 | 0 | 0 | |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VEF MANAGEMENT III LLC | 10% Owner | Option Exercise | C | 0.00 | 137,765 | 0 | 0 | |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VEF MANAGEMENT III LLC | 10% Owner | Buy | C | 0.00 | 15,668 | 0 | 50,439 | 34.8 K to 50.4 K (+45.06 %) |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VEF MANAGEMENT III LLC | 10% Owner | Buy | C | 0.00 | 34,771 | 0 | 34,771 | 0 to 34.8 K |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 71,764 | 0 | 0 | |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 2,870,582 | 0 | 0 | |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 645,881 | 0 | 0 | |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 137,765 | 0 | 0 | |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 5,510,611 | 0 | 0 | |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 1,239,889 | 0 | 0 | |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | EVNIN ANTHONY B | Director | Buy | C | 0.00 | 15,668 | 0 | 50,439 | 34.8 K to 50.4 K (+45.06 %) |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | EVNIN ANTHONY B | Director | Buy | C | 0.00 | 34,771 | 0 | 34,771 | 0 to 34.8 K |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | EVNIN ANTHONY B | Director | Buy | C | 0.00 | 626,764 | 0 | 2,017,630 | 1.4 M to 2 M (+45.06 %) |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | EVNIN ANTHONY B | Director | Buy | C | 0.00 | 1,390,866 | 0 | 1,390,866 | 0 to 1.4 M |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | EVNIN ANTHONY B | Director | Buy | C | 0.00 | 141,022 | 0 | 453,967 | 312.9 K to 454 K (+45.06 %) |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | EVNIN ANTHONY B | Director | Buy | C | 0.00 | 312,945 | 0 | 312,945 | 0 to 312.9 K |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R& D, Chief Sc ... | Option Exercise | C | 0.22 | 40,625 | 8,856 | 0 | |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | Krieg Arthur M | SVP, R& D, Chief Sc ... | Buy | C | 0.00 | 8,870 | 0 | 601,883 | 593 K to 601.9 K (+1.50 %) |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VENROCK ENTREPRENEURS FUND III ... | 10% Owner | Option Exercise | C | 0.00 | 71,764 | 0 | 0 | |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VENROCK ENTREPRENEURS FUND III ... | 10% Owner | Option Exercise | C | 0.00 | 137,765 | 0 | 0 | |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VENROCK ENTREPRENEURS FUND III ... | 10% Owner | Buy | C | 0.00 | 15,668 | 0 | 50,439 | 34.8 K to 50.4 K (+45.06 %) |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VENROCK ENTREPRENEURS FUND III ... | 10% Owner | Buy | C | 0.00 | 34,771 | 0 | 34,771 | 0 to 34.8 K |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VENROCK ASSOCIATES III LP | 10% Owner | Option Exercise | C | 0.00 | 2,870,582 | 0 | 0 | |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VENROCK ASSOCIATES III LP | 10% Owner | Option Exercise | C | 0.00 | 5,510,611 | 0 | 0 | |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VENROCK ASSOCIATES III LP | 10% Owner | Buy | C | 0.00 | 626,764 | 0 | 2,017,630 | 1.4 M to 2 M (+45.06 %) |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VENROCK ASSOCIATES III LP | 10% Owner | Buy | C | 0.00 | 1,390,866 | 0 | 1,390,866 | 0 to 1.4 M |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VENROCK ASSOCIATES | 10% Owner | Option Exercise | C | 0.00 | 645,881 | 0 | 0 | |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VENROCK ASSOCIATES | 10% Owner | Option Exercise | C | 0.00 | 1,239,889 | 0 | 0 | |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VENROCK ASSOCIATES | 10% Owner | Buy | C | 0.00 | 141,022 | 0 | 453,967 | 312.9 K to 454 K (+45.06 %) |
Aug 16 2005 | COLY | Coley Pharmaceutic ... | VENROCK ASSOCIATES | 10% Owner | Buy | C | 0.00 | 312,945 | 0 | 312,945 | 0 to 312.9 K |
Aug 15 2005 | COLY | Coley Pharmaceutic ... | THOMAS MCNERNEY & PARTNERS LP | 10% Owner | Option Exercise | C | 0.00 | 3,316 | 0 | 0 | |
Aug 15 2005 | COLY | Coley Pharmaceutic ... | THOMAS MCNERNEY & PARTNERS LP | 10% Owner | Option Exercise | C | 0.00 | 7,028 | 0 | 0 | |
Aug 15 2005 | COLY | Coley Pharmaceutic ... | THOMAS MCNERNEY & PARTNERS LP | 10% Owner | Option Exercise | C | 0.00 | 677,858 | 0 | 0 | |
Aug 15 2005 | COLY | Coley Pharmaceutic ... | THOMAS MCNERNEY & PARTNERS LP | 10% Owner | Option Exercise | C | 0.00 | 2,088,616 | 0 | 0 | |
Aug 15 2005 | COLY | Coley Pharmaceutic ... | THOMAS MCNERNEY & PARTNERS LP | 10% Owner | Buy | C | 0.00 | 3,316 | 0 | 2,776,818 | 2.8 M to 2.8 M (+0.12 %) |
Aug 15 2005 | COLY | Coley Pharmaceutic ... | THOMAS MCNERNEY & PARTNERS LP | 10% Owner | Buy | C | 0.00 | 7,028 | 0 | 2,773,502 | 2.8 M to 2.8 M (+0.25 %) |
Aug 15 2005 | COLY | Coley Pharmaceutic ... | THOMAS MCNERNEY & PARTNERS LP | 10% Owner | Buy | C | 0.00 | 677,858 | 0 | 2,766,474 | 2.1 M to 2.8 M (+32.45 %) |
Aug 15 2005 | COLY | Coley Pharmaceutic ... | THOMAS MCNERNEY & PARTNERS LP | 10% Owner | Buy | C | 0.00 | 2,088,616 | 0 | 2,088,616 | 0 to 2.1 M |
Aug 15 2005 | COLY | Coley Pharmaceutic ... | THOMAS JAMES E | Director | Option Exercise | C | 0.00 | 3,316 | 0 | 0 | |
Aug 15 2005 | COLY | Coley Pharmaceutic ... | THOMAS JAMES E | Director | Option Exercise | C | 0.00 | 7,028 | 0 | 0 | |
Aug 15 2005 | COLY | Coley Pharmaceutic ... | THOMAS JAMES E | Director | Option Exercise | C | 0.00 | 25,218 | 0 | 0 |